Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on May 19, 2026

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Ozari Health Launches Nationwide Telehealth Platform for Compounded Semaglutide and Tirzepatide Starting at $86 Per Month
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants
Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Iridex Reports First Quarter 2026 Financial Results
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
Suja Life to Report First Quarter 2026 Financial Results on June 9, 2026
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases
NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology
Relay Therapeutics Announces Proposed Public Offering of Common Stock
Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit
Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity
Ipsen annonce des données « late-breaking » issues de la première étude comparative directe entre Dysport® et Botox® chez des adultes atteints de spasticité du membre supérieur
Oorja Bio Launches as a Clinical-Stage Company to Develop Groundbreaking Therapies for Idiopathic Pulmonary Fibrosis (IPF) and Other Fibrotic Diseases
Oorja Bio Unveils Clinical Data for ORJ-001, a First-in-Class Therapeutic Targeting Alveolar Epithelial Type 2 (AEC2) Cells for Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Hemet Global Medical Center Announces New Ambulance Bay, EMS Lounge, and Cardiovascular Operating Room During 2026 EMS Week
Fantastic Services Unveils New Report Warning Private Landlords Over Rising Legal Exposure to Damp and Mould Claims

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Wire Texas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.